Pharmacotherapies for cannabis dependence

Source:
Cochrane Database of Systematic Reviews
Publisher:
Cochrane Database of Systematic Reviews
Publication date:
28 January 2019

Abstract

Review of 21 RCTs (n=1755) noted incomplete evidence for all of pharmacotherapies investigated, and for many outcomes quality of evidence was low .Findings indicate SSRI and mixed action antidepressants, bupropion, buspirone and atomoxetine are probably of little value.